JP Morgan Chase
RVMD icon

JP Morgan Chase’s Revolution Medicines RVMD Stock Holding History

JP Morgan Chase’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Sell
76,800
-51,200
-40% -$7.48M ﹤0.01% 2461
2026
Q1 		$11.9M Buy
+128,000
New +$12.9M ﹤0.01% 2523
2025
Q1 		– Sell
-3,200
Closed -$140K – 7670
2024
Q4 		$140K Sell
3,200
-53,900
-94% -$2.72M ﹤0.01% 5625
2024
Q3 		$2.59M Buy
57,100
+53,900
+1,684% +$2.35M ﹤0.01% 3788
2024
Q2 		$124K Buy
+3,200
New +$120K ﹤0.01% 5410
2023
Q4 		– Sell
-135,000
Closed -$3.74M – 7829
2023
Q3 		$3.74M Buy
+135,000
New +$4M ﹤0.01% 3054

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

JP Morgan Chase's RVMD Position: Q2 2026 in Review

JP Morgan Chase increased its Revolution Medicines (RVMD) stake by 994% in Q2 2026, buying an estimated $438M and bringing the position to 3,298,066 shares worth $637M. The position accounts for 0.04% of the portfolio, ranked #392.

JP Morgan Chase first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • JP Morgan Chase held 3,298,066 shares of Revolution Medicines worth $637M as of Q2 2026.
  • JP Morgan Chase bought 2,996,673 Revolution Medicines shares in Q2 2026, an estimated $438M.
  • Revolution Medicines made up 0.04% of JP Morgan Chase's portfolio in Q2 2026, its #392 holding.
  • JP Morgan Chase first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.